Primary record
PF 2341066;(R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine
- 库存
- 3,696 克
- 纯度
- 99.5 %
- CAS
- 877399-52-5
化合物标识与属性
- CAS
- 877399-52-5
- PubChem CID
- 11626560
- SMILES
- C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N
- Canonical SMILES
- C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl
名称与同义词
- Crizotinib
- Xalkori
- 877399-52-5
- (R)-crizotinib
- crizotinibum
- Xalkori (TN)
- Crizotinib [USAN]
- PF-02341066
- PF-2341066
- novel ALK inhibitors
- Crizotinib (Standard)
- Crizotinib [USAN:INN]
- Crizotinib (PF-02341066)
- CRIZOTINIB [MI]
- RefChem:57397
- CRIZOTINIB [INN]
- CRIZOTINIB [JAN]
- C21H22Cl2FN5O
- PF 2341066
- CRIZOTINIB [VANDF]
- MFCD12407409
- D03ZBT
- CRIZOTINIB [MART.]
- CHEMBL601719
- CRIZOTINIB [WHO-DD]
- SCHEMBL93829
- Crizotinib (PF-2341066)
- PF-2341066,Crizotinib
- UNII-53AH36668S
- cc-190
- CHEBI:64310
- PF 02341066
- Crizotinib (JAN/USAN/INN)
- PF-2341066(Crizotinib)
- Crizotinib - Bio-X trade mark
- DTXSID701009329
- GTPL4903
- orb1307848
- QCR-32
- 53AH36668S
- CRIZOTINIB [ORANGE BOOK]
- Crizotinib, >=98% (HPLC)
- NSC-756645
- PF-2341066 (Crizotinib)
- PF-2341066 - Crizotinib
- SCHEMBL29351506
- SCHEMBL29622387
- CTK5F8952
- 877399-52-5 (free base)
- AOB2688
- EX-A096
- L01XE16
- PF2341066
- SYN1139
- Crizotinib (PF-2341066)?
- KTEIFNKAUNYNJU-GFCCVEGCSA-N
- PF-02341066 (Crizotinib)
- BCPP000116
- DTXCID601436157
- GLXC-04599
- AMX10152
- AMY10313
- MSK10718
- Crizotinib, 98% - 10MG 10mg
- ABP000131
- ANW-47749
- BDBM50306682
- EBC-12789
- HY-50878R
- NSC749005
- NSC749769
- NSC800080
- ZINC35902489
- (R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine
- AKOS015901233
- AKOS015995207
- 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine
- ACN-031532
- CCG-264803
- CS-0029
- DB08865
- FD20585
- GS-6178
- NSC 756645
- NSC-749005
- NSC-749769
- NSC-800080
- RL05464
- SDCCGSBI-0647655.P002
- CID11626560
- KS-0000075X
- NCGC00250400-01
- NCGC00250400-02
- NCGC00250400-09
- NCGC00250400-12
- PF02341066
- BC164334
- BC622990
- BP-43636
- CID:11626560
- EN002685
- HY-50878
- SC-48062
- SID:376229599
- 3-[(1R)-1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY]-5-[1-(4-PIPERIDINYL)-1H-PYRAZOL-4-YL]PYRIDIN-2-AMINE
- AB0027203
- TX-017903
- A3020
- BB 0261738
- NS00072165
- S1068
- SW202555-3
- W9013
- J2.735.431I
- MET Tyrosine Kinase Inhibitor PF-02341066
- A10455
- A10712
- D09731
- Q-3209
- 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine
- 399P525
- A904058
- C520390
- C551994
- F793129
- Q5186964
- BRD-K78431006-001-01-1
- BRD-K78431006-001-03-7
- BRD-K78431006-001-10-2
- BRD-K78431006-001-11-0
- I14-14837
- 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[
- 877399-52-5, 877399-53-6 (acetate)
- D000077547
- Z2065417924
- B2693-452205
- 2-Pyridinamine, 3-((1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(4-piperidinyl)-1H-pyrazol-4-yl)-
- 3-[(1r)-1-(2,6-Dichloro-3-Fluorophenyl)ethoxy]-5-(1-Piperidin-4-Yl-1h-Pyrazol-4-Yl)pyridin-2-Amine
- 2-PYRIDINAMINE, 3-[(1R)-1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY]-5-[1-(4-PIPERIDINYL)-1H-PYRAZOL-4-YL]-
- 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine
- 877399-53-6
- 3-(2,6-dichloro-3-fluorobenzyloxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine
- (R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-am ine
- (R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine
- (R)-3-[1-(2,6-Dichloro-3-fluorop henyl)ethoxy]-5-(1-piperidin-4-yl-1H- pyrazol-4-yl)pyridin-2-ylamine
- 3-((1r)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(4-piperidinyl)-1h-pyrazol-4-yl)pyridin-2-amine
- 3-((1R)-1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY)-5-(1-(PIPERIDIN-4-YL)-1H-PYRAZOL-4-YL)PYRIDIN-2-AMINE
- 3-(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy-5-1-(4-piperidinyl)-1H-pyrazol-4-yl-2-Pyridinamine
- 3-[(1R)-1-(2,6-dichloro-3-fluoro-phenyl)ethoxy]-5-[1-(4-piperidyl)pyrazol-4-yl]pyridin-2-amine
- 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyra zol-4-yl]-2-pyridinamine
- 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazole-4-yl]-2-pyridineamine
- 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidine-4-yl)-1H-pyrazole-4-yl]pyridine-2-amine
- 3-[(R)-1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine
- 3-[[(R)-alpha-Methyl-2,6-dichloro-3-fluorobenzyl]oxy]-5-[1-(4-piperidinyl)-1H-pyrazole-4-yl]-2-pyridineamine
- 3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine
- 3-[1-(2,6-dichloro-3-fluoro-phenyl)ethoxy]-5-[1-(4-piperidyl)pyrazol-4-yl]pyridin-2-amine
- 638-814-9
- PF 2341066;(R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine
- VGH